Neon Therapeutics Inc (NTGN) Stock Overview
USA - NASDAQ:NTGN -
NTGN Key Statistics, Chart & Performance
The current stock price of NTGN is 3.07 null. In the past month the price increased by 19.46%. In the past year, price decreased by -46.7%.
NTGN Latest News, Press Relases and Analysis
About NTGN
Company Profile
Neon Therapeutics Inc. is a clinical-stage immuno-oncology company. It engaged in developing neoantigen-based therapeutics for the treatment of cancer by directing the immune system. The company's product pipeline consists of NEO-PV-01, NEO-PTC-01 and NEO-SV-01 which are in clinical stage. Neon Therapeutics Inc. is based in Cambridge, United States.
Company Info
Neon Therapeutics Inc
40 ERIE STREET SUITE 110
CAMBRIDGE MA 02139
CEO: Hugh O`Dowd
Phone: 617-337-4701
Neon Therapeutics Inc / NTGN FAQ
What is the stock price of Neon Therapeutics Inc today?
The current stock price of NTGN is 3.07 null. The price increased by 8.1% in the last trading session.
What is the ticker symbol for Neon Therapeutics Inc stock?
The exchange symbol of Neon Therapeutics Inc is NTGN and it is listed on the Nasdaq exchange.
On which exchange is NTGN stock listed?
NTGN stock is listed on the Nasdaq exchange.
What is Neon Therapeutics Inc worth?
Neon Therapeutics Inc (NTGN) has a market capitalization of 88.93M null. This makes NTGN a Micro Cap stock.
What are the support and resistance levels for Neon Therapeutics Inc (NTGN) stock?
Neon Therapeutics Inc (NTGN) has a support level at 2.76 and a resistance level at 3.08. Check the full technical report for a detailed analysis of NTGN support and resistance levels.
Should I buy Neon Therapeutics Inc (NTGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NTGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NTGN, evaluating the profitability, health, valuation and growth aspects
- Neon Therapeutics Inc (NTGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Neon Therapeutics Inc (NTGN) Sales and EPS estimates to see what analysts future expectations are.
- Neon Therapeutics Inc (NTGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Neon Therapeutics Inc (NTGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- Neon Therapeutics Inc (NTGN) Stock Chart to make your own analysis
- Neon Therapeutics Inc (NTGN) Latest news and press-releases to stay up to date.
Does Neon Therapeutics Inc (NTGN) stock pay dividends?
NTGN does not pay a dividend.
What is the Price/Earnings (PE) ratio of Neon Therapeutics Inc (NTGN)?
Neon Therapeutics Inc (NTGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.86).
NTGN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to NTGN. When comparing the yearly performance of all stocks, NTGN is one of the better performing stocks in the market, outperforming 94.62% of all stocks.
NTGN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NTGN. NTGN has a bad profitability rating. Also its financial health evaluation is rather negative.
NTGN Financial Highlights
Over the last trailing twelve months NTGN reported a non-GAAP Earnings per Share(EPS) of -2.86. The EPS increased by 48.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -239.95% | ||
| ROE | N/A | ||
| Debt/Equity | 0.43 |